117 results on '"Ekenel, M."'
Search Results
2. Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)
3. Sunitinib versus pazopanib para el tratamiento del carcinoma de células renales metastásico: experiencia en 2 hospitales turcos
4. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
5. FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens: 3729
6. Scleredema of Buschke associated with Waldenström's macroglobulinaemia
7. COMPARISON OF THROMBOPOIETIN LEVELS IN PATIENTS WITH CHRONIC LIVER DISEASE
8. Induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma (NPC)
9. The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients
10. Remitting Seronegative Symmetrical Synovitis with Pitting Oedema Associated with Chronic Lymphocytic Leukaemia
11. 781P Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab
12. Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: Two Turkish hospital experience, a retrospective comparative case series study
13. 1143P - Induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma (NPC)
14. Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer
15. Comparison of RC Beams Strengthened with FRP and Pre-Cured Laminate Systems & Tested Under Fatigue and Flexural Loadings
16. Acousto-Ultrasonic Technology for Non-Destructive Evaluation of Concrete Bridge Members Strengthened by CFRP
17. 885P - Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: Two Turkish hospital experience, a retrospective comparative case series study
18. Prognostic Factors Associated with the Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma
19. Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)
20. Response Rates and Adverse Effects of Continuous Once-daily Sunitinib in Patients with Advanced Renal Cell Carcinoma: A Single-center Study in Turkey
21. Does the Timing of Radiotherapy Impact Survival of Glioblastoma Multiforme Patients?
22. The First Case of Primary Testicular Germ Cell Tumor Containing Nephroblastoma as the Only One Non-germ Cell Component
23. Comparison of two different adjuvant treatment approaches for patients with locally advanced gastric cancer.
24. Clinical outcomes in patients with locally advanced nasopharyngeal cancer treated with neoadjuvant docetaxel and cisplatin followed by radiation treatment and concomitant cisplatin.
25. Surveillance results of patients with stage I nonseminomatous testis cancer.
26. 2502 ORAL Does initial response to corticosteroids predict survival in primary CNS lymphoma (PCNSL)?
27. What is the role of whole brain radiation therapy (WBRT) and high-dose cytarabine (Ara-C) as consolidation treatment after initial chemotherapy for primary CNS lymphoma (PCNSL)?
28. P-502 Outcome of patients with stage III and IV non-small cell lungcancer in Marmara University Hospital, Istanbul, Turkey
29. VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival
30. Outcome of adjuvant treatment in elderly Turkish breast cancer patients
31. Clinical and pathological characteristics of early breast cancer (EBC) patients <35 years old
32. Durability Performance of Bridge Concretes, Part I: High Performance Concrete (HPC)
33. Durability Performance of Bridge Concretes, Part II: High-Strength Concrete (HSC)
34. Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC)
35. Prognostic value of thymidylate synthase and cox-2 expression in colorectal cancer patients' tumors
36. Human papilloma virus: Is it a new etiological factor in breast cancer?
37. FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens
38. Is the incidence of anal canal cancers different in Moslem societies?
39. Attitude toward genetic testing in Turkish society
40. Port needles: do they need to be removed as frequently in infusional chemotherapy?
41. Comparison of two different adjuvant treatment approaches for patients with locally advanced gastric cancer
42. Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort.
43. Comparison of second-line treatments in metastatic renal cell carcinoma patients: A single-center experience.
44. The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience.
45. Clinical course and features of soft tissue sarcomas in geriatric patients: a single-center experience.
46. Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.
47. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
48. A rare case of ruptured liver metastases from a laryngeal cancer.
49. Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04.
50. Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.